Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.

[1]  Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients , 2014, Genome Medicine.

[2]  M. Finegold,et al.  β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. , 2014, Cancer research.

[3]  Yukichi Tanaka,et al.  Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium , 2014, Modern Pathology.

[4]  Khin Thway,et al.  Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo , 2013, Clinical Cancer Research.

[5]  Jun-hua Lu,et al.  Concomitant lung metastasis in patients with advanced hepatocellular carcinoma. , 2012, World journal of gastroenterology.

[6]  P. Ruck,et al.  Successful Establishment of an Orthotopic Hepatoblastoma In Vivo Model in NOD/LtSz-scid IL2Rγnull Mice , 2011, PloS one.

[7]  G. Perilongo,et al.  Pediatric Liver Tumors , 2011 .

[8]  Prahlad T. Ram,et al.  Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells. , 2010, Cancer research.

[9]  D. Rakheja,et al.  Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor , 2009, Pediatric blood & cancer.

[10]  I. Verma,et al.  Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal model , 2007, Proceedings of the National Academy of Sciences.

[11]  Aarati R. Ranade,et al.  Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice , 2007, Nature Biotechnology.

[12]  B. Dutrillaux,et al.  Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. , 2007, Cancer research.

[13]  J. Birch,et al.  Relationships between perinatal and maternal characteristics and hepatoblastoma: a report from the UKCCS. , 2005, European journal of cancer.

[14]  M. Kotb,et al.  Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 , 2004, The Journal of Immunology.

[15]  Christopher H. Contag,et al.  MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.

[16]  I. Fidler,et al.  Orthotopic Models are Necessary to Predict Therapy of Transplantable Tumors in Mice , 1998, Cancer and Metastasis Reviews.

[17]  R. Kerbel,et al.  Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis , 1991, Cancer and Metastasis Reviews.

[18]  P. Schofield,et al.  Wiedemann-beckwith syndrome , 1988, European Journal of Pediatrics.

[19]  W. Behnisch,et al.  Two novel in vitro human hepatoblastoma models, HepU1 and HepU2, are highly characteristic of fetal–embryonal differentiation in hepatoblastoma , 2003, International journal of cancer.

[20]  Mamoru Ito,et al.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. , 2002, Blood.

[21]  Y. Ueyama,et al.  Functional Human T Lymphocyte Development from Cord Blood CD34+ Cells in Nonobese Diabetic/Shi-scid, IL-2 Receptor γ Null Mice1 , 2002, The Journal of Immunology.

[22]  P. Lichter,et al.  Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. , 2000, The American journal of pathology.

[23]  M. Iwafuchi,et al.  A study of therapy for pediatric hepatoblastoma: prevention and treatment of pulmonary metastasis. , 1999, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[24]  J. Feusner,et al.  Prematurity and hepatoblastoma: more than just an association? , 1998, The Journal of pediatrics.

[25]  H. Ikeda,et al.  Association between hepatoblastoma and very low birth weight: a trend or a chance? , 1997, The Journal of pediatrics.

[26]  D. V. von Schweinitz,et al.  Successful transplantation of human hepatoblastoma into immunodeficient mice. , 1996, Journal of pediatric surgery.

[27]  C. Fonatsch,et al.  Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[28]  J. Sobczak-Thépot,et al.  Proliferation and differentiation of a human hepatoblastoma transplanted in the Nude mouse. , 1995, Journal of hepatology.

[29]  K. Manchester,et al.  Establishment and characterization of a novel hepatoblastoma-derived cell line. , 1995, Journal of pediatric surgery.

[30]  R. Hoffman,et al.  Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. , 1993, Anticancer research.

[31]  J. Mann,et al.  Association between hepatoblastoma and polyposis coli. , 1983, Archives of disease in childhood.

[32]  Establishment of an experimental model of human hepatoblastoma , 1982, Cancer.

[33]  Ivan Damjanov,et al.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line , 1979, Nature.

[34]  I. Doi.  Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma. , 1976, Gan.

[35]  J. Orgaz.  [Hepatic tumors]. , 1952, Revista medica de Cordoba.